Jacobs Levy Equity Management, Inc Synlogic, Inc. Call Options Transaction History
Jacobs Levy Equity Management, Inc
- $23.2 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SYBX
# of Institutions
2Shares Held
25.5KCall Options Held
0Put Options Held
0About SYNLOGIC, INC.
- Ticker SYBX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,229,600
- Market Cap $103M
- Description
- Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...